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Abstract 
Background: A number of studies have shown central adiposity, in particular visceral adipose tissue (VAT) accumula-
tion to be a hallmark of metabolic syndrome (MetS). In clinical practice, waist circumference (WC) is used as a proxy 
for VAT.
Aim: To compare the ability of dual energy x-ray absorptiometry (DXA)-derived VAT area and anthropometric meas-
ures of adiposity for diagnosing MetS in a sample of high risk South African women.
Methods: MetS was quantified using the Joint Interim Statement (JIS) criteria. Fasting glucose, insulin and lipid pro-
file were measured in 204 post-menopausal women. Anthropometry measures included body mass index (BMI), WC, 
waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and a body shape index (ABSI). The area under the curve (AUC) 
was used to assess their performance in detecting any two components of MetS (excluding WC). Optimal WC and VAT 
area cut-points were derived to compare their performance for diagnosing MetS and to compare to internationally 
recognised cut-points.
Results: The highest AUC for the prediction of MetS was recorded for VAT, followed by WHtR and WC (AUC, 0.767, 
0.747 and 0.738 respectively), but these did not differ significantly (all p ≥ 0.192). In contrast, VAT was significantly 
better than BMI (p = 0.028), hip (p = 0.0004) and ABSI (p < 0.0001). The optimal WC (94.4 cm) and VAT area (174 cm2 
based on the Youden’s index method and 175.50 cm2 based on the CTL approach) cut-points performed similarly in 
detecting MetS.
Conclusion: DXA-derived VAT and WC had the same overall performance in discriminating the presence of any 2 
MetS components in high risk South African women. These findings support the current recommendations of using 
WC rather than VAT for MetS risk screening, as it is cheap, accessible and easy to measure.
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Introduction
The International Diabetes Federation estimates the 
global prevalence of MetS to be around 25% [1, 2]. Pre-
vious research in South Africa showed that the mixed 
ancestry population were a high risk group for MetS [3]. 
It is therefore essential in a high risk population like this 
that one is able to identify those at risk and introduce 
lifestyle modifications.
Typically WC is the accepted proxy of visceral adipose 
tissue (VAT) and measure of central adiposity, and is 
used in the clinical diagnosis of MetS [4]. The advantage 
of WC is that it is quick and easy to measure and does not 
require technical equipment [5, 6]. Other anthropomet-
ric measures of total adiposity and body fat distribution 
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such as BMI, WC, hip circumference (HC), waist to 
height ratio (WHtR), waist to hip ratio (WHR) and more 
recently, a body shape index (ABSI) have also been used 
as indicators of cardiometabolic risk [7]. All have their 
benefits, as well as their weaknesses. For example, while 
BMI is most commonly used as an indicator of total adi-
posity, it does not differentiate between muscle and fat 
or the location of fat [8]. WHtR, unlike WC thresholds, 
takes into account body size [8] and has shown closer 
agreement of values between men and women at all ages 
[9]. Similarly, the ABSI takes into account body size and 
is based on the WC adjusted for height and weight [10]. 
In contrast, WHR, uses the ratio of WC and HC, how-
ever the practicality of measuring 2 circumferences may 
be cumbersome and prone to error [11].
While metabolic abnormalities can be due to differential 
distribution of adipose tissue and or adipose dysfunction 
[12], a major limitation of WC, and other anthropomet-
ric measurements, is the inability to discriminate between 
VAT and subcutaneous adipose tissue (SAT) [6, 13]. Find-
ings of the Framingham heart study revealed that both 
SAT and VAT correlated with metabolic risk factors, but 
that VAT was more powerfully associated with an unfa-
vourable metabolic risk profile even after accounting for 
easily measured anthropometric indexes such as BMI and 
WC [14]. The mechanisms linking VAT accumulation to 
metabolic complications involve the greater production 
of proinflammatory cytokines and the greater lipolytic 
action compared to SAT, with the resultant increase in 
cytokines and free fatty acid transfer to the hepatic portal 
system impacting on insulin sensitivity [15].
In the clinical setting, VAT is however difficult to 
measure as it requires expensive technical equipment 
for imaging [6, 13, 16]. Although computed tomography 
(CT) and magnetic resonance imaging (MRI) are con-
sidered the gold standard imaging methods for quanti-
fying body fat and its distribution, reliable algorithms 
have been developed using dual x-ray absorptiometry 
(DXA) software. These have been validated against CT 
in women with varying body mass index (BMI) [17, 18]. 
Numerous studies in various populations have identified 
associations between DXA-derived VAT area and cardio-
metabolic risk factors [19–22]. Although waist circum-
ferences may be similar, ethnic variations in VAT and 
subcutaneous (SAT) have been documented amongst 
different ethnic groups [15]. Few studies have attempted 
to measure VAT in African populations and more specifi-
cally in the mixed ancestry women of South Africa where 
the prevalence of MetS is high.
The main aim of the study was to compare the ability 
of DXA-derived VAT area and anthropometry measures 
of total and central adiposity for diagnosing MetS in this 
high-risk sample of South African women.
Materials and methods
Study setting and population
Participants
The current study data was collected from participants 
from the Cape Town Vascular and Metabolic Health 
(VMH) study, an extension of the Cape Town Bellville 
South study described previously [23, 24]. A mixed race 
was chosen as this population accounts for 8.9% of the 
South African population, 48.8% of the population of the 
Western Cape Province and 76% of the geographical area 
surveyed. This population has a high prevalence of MetS 
and type-2 diabetes [3], and therefore risk detection is 
key to early prevention and management.
Self-described mixed-ancestry female volunteers who 
took part in the above mentioned cross-sectional study 
were invited to complete a whole body DXA scan. The 
DXA scans were performed from April 2015 to June 
2016. Being 20 years or older was an inclusion criterion. 
Subjects were excluded if they were pregnant or acutely 
ill. Ethical approval was obtained from the Ethics Com-
mittees of the Cape Peninsula University of Technology 
and Stellenbosch University (NHREC: REC-230 408-014, 
CPUT/HWS-REC 2015/H03 and N14/01/003). Par-
ticipants provided written consent to participate in the 
study. A total of 204 women volunteered for the study.
Body composition
Anthropometric measurements were taken, as described 
in detail previously [3, 24]. Body weight was measured (to 
the nearest 0.1 kg) with the participants in light clothing 
and without shoes. Height was measured to the nearest 
centimetre using a stadiometer. BMI was calculated as 
weight divided by height in square meters (kg/m2). Waist 
circumference was measured using a non-elastic tape at 
the level of the narrowest part of the torso as seen in an 
antero-posterior projection and hip circumference 
around the widest part of the buttocks. The WHtR is cal-
culated as the waist measurement divided by the height, 
while WHR is calculated as waist measurement divided 
by the hip measurement. ABSI was based on WC 
adjusted for weight and height, and was calculated using 
the formula, ABSI = WC
BMI2/3height1/2
 [10]. All anthropo-
metric measurements were performed three times, and 
the average measurements were used for analysis.
Body composition (fat mass and fat-free mass) was 
acquired by a trained and experienced radiographer 
using a Hologic Discovery W DXA whole body scan-
ner configured with software version 13.4.1 (Hologic, 
Bedford, MA). Participants were positioned as per the 
NHANES body composition manual as advocated by 
Hangartner [25]. VAT and SAT area were estimated 
within the android region, which is automatically defined 
with a caudal limit placed on top of the iliac crests and its 
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height set to 20% of the distance from the top of the iliac 
crest to the base of the skull as the cephalic limit [18]. 
DXA has proved to be as accurate as a clinical CT scan in 
the quantification of VAT and SAT in adults [18]. Subto-
tal body fat % and kg, which excludes the head, were used 
in the analysis. The head was excluded to reduce the pos-
sibility of any artefacts in the head region. Total adipose 
body tissue classification excludes the head.
Blood sample collection and analysis
After an overnight fast, blood samples were taken to 
measure glycated haemoglobin  (HbA1c), glucose, insulin 
and lipid profile. Blood samples were transported daily 
on ice for processing using standard pathology practices. 
Biochemical parameters were analysed at an ISO 15189 
accredited Pathology practice (Pathcare, Reference Labo-
ratory, Cape Town, South Africa) as described elsewhere 
[24]. Plasma glucose was measured by the enzymatic 
hexokinase method (Beckman AU, Beckman Coulter, 
South Africa). Insulin was measured by paramagnetic 
particle chemiluminescence assay (Beckman DXI, Beck-
man Coulter, South Africa). High-density lipoprotein 
cholesterol (HDL-C) was by enzymatic immunoinhibi-
tion, and triglycerides by glycerol phosphate oxidase–
peroxidase and Low density lipoprotein cholesterol 
(LDL-C) by enzymatic selective protection—End Point 
(Beckman AU, Beckman Coulter, South Africa).
Metabolic syndrome was quantified using the Joint 
Interim Statement (JIS) criteria [4], namely the pres-
ence of any 3 risk factors: WC ≥ 80  cm, elevated tri-
glycerides ≥ 1.7  mmol/L (or drug treatment for elevated 
levels), elevated blood pressure systolic ≥ 130 and/or 
diastolic ≥ 85  mmHg (or antihypertensive drug treat-
ment), elevated fasting blood glucose ≥ 5.6  mmol/L 
(or drug treatment of elevated glucose) and reduced 
HDL-C < 1.3  mmol/L (or drug treatment for reduced 
HDL-C). In our analysis we excluded WC in the discrimi-
nation of MetS as WC is part of the JIS MetS criteria, but 
used DXA-VAT as an independent variable to discrimi-
nate those with MetS.
Statistical methods
General characteristics of the study groups are summa-
rized as count and percentage for categorical variables, 
mean and standard deviation (SD) or median and 25th–
75th percentiles for quantitative variables. The pROC 
package [26] of the R statistical software version 3.4.3 
(30 Nov 2017), (The R Foundation for Statistical Com-
puting, Vienna, Austria) was used for receiver operating 
characteristics (ROC) analyses. The area under the curve 
(AUC) was then used to assess and compare the ability of 
VAT area, WC, BMI, WHR, WHtR and ABSI to predict 
the presence of any two components of metabolic syn-
drome, excluding WC, with AUC comparisons through 
non-parametric methods [27]. The optimal WC and VAT 
area was determined by applying both the Youden’s index 
approach [28] and the closest top left point approach 
[29]. For comparison purposes, the optimal VAT and WC 
thresholds derived for this sample were tested alongside 
cut points commonly advocated in African and other 
populations [4, 30, 31].
Results
Participant characteristics
The characteristics of the participants are presented 
in Table  1. The mean age of the participants was 53.1 
(± 13.7) years. The mean BMI was 32.6 (± 7.2), with 
19.8% of the participants being overweight, and the 
majority (64.7%) obese. Twenty seven percent were clas-
sified as having diabetes and 57.1% had MetS, with 88.7% 
presenting with a WC ≥ 80  cm. The median VAT area 
was 181 cm2. The most prevalent MetS components after 
the high WC, was high blood pressure (74%), low HDL 
(48%) with triglycerides (34.3%) and high fasting glucose 
(33.5%) being the least frequent component.
Discriminatory power of anthropometric variables and VAT 
for the prediction of metabolic syndrome
The discriminatory power of all anthropometric variables 
and VAT area for the prediction of any two JIS-defined 
components of MetS (excluding WC, as this is part of the 
MetS criteria) is shown in Table 2. The highest point esti-
mate of AUC for the prediction of MetS was recorded for 
VAT, followed by WHtR and WC (AUC, 0.767, 0.747 and 
0.738 respectively), but these did not differ significantly 
(all p ≥ 0.192). In contrast, VAT had significantly greater 
discriminatory power than BMI (p = 0.028), and VAT, 
WHtR and WC had greater discriminatory power than 
hip (p < 0.0004) and ABSI (p < 0.0001).
Optimal waist circumference and VAT threshold values
Given that WC is commonly used as a proxy for VAT in 
the clinical setting, we examined the thresholds for WC 
and VAT area to diagnose MetS (excluding WC) in this 
sample. The receiver operating characteristic curves 
(ROC) for the prediction of the presence of at least two 
components of MetS using WC or VAT area are pre-
sented in Fig. 1. The Youden’s index method and the CTL 
approach used to derive the optimal WC threshold values 
in this sample identified the same threshold of 94.4  cm 
(Table 3). The optimal VAT area threshold was 174 cm2 
based on the Youden’s index method and 175.50  cm2 
based on the CTL approach.
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The WC cut-point of 94.4 cm in this sample yielded a 
sensitivity of 61.4% and specificity of 80.8%. The sensitiv-
ity of this cut-point was higher than the recommended 
JIS ≥ 80  cm WC (20.5%) cut-point, and the 90  cm WC 
(48.2%) cut-point recommended by Matsha and co-work-
ers for both genders in the larger study of this population 
[31]. Conversely, the specificities of the WC derived for 
this sample (80.8%) was lower than that for the JIS crite-
ria (95.8%) and the larger study in this population (89.2%) 
[31]. The sensitivity and specificity of the 174  cm2 VAT 
thresholds obtained from the Youden index were 72.3% 
and 70% respectively.
When comparing the sensitivity and specificity of WC 
and VAT cut-points for predicting any two components 
of MetS in this population, the sensitivity of the VAT area 
cut-point was greater than WC (72.3% vs 61%), however 
the specificity of VAT area was less than WC (70% vs 
80.8%). When comparing the accuracy of VAT and WC 
for predicting any two components of MetS, they were 
very similar (70.9–72.3%, for Youden index and CTL). 
Further, the positive predictive values (PPV) were similar 
for VAT area and WC in diagnosing any two components 
of MetS (63% vs 69%) with similar 95% CI’s. The likeli-
hood of a positive test  (LH+) for VAT area and WC were 
also similar (2.1–2.45 vs 3.21 respectively).
Discussion
In this study we set out to compare the discriminatory 
power of DXA-derived VAT area and other anthropo-
metric measurements to diagnose any two components 
of MetS in a sample of high-risk mixed ancestry women 
from South Africa. The main finding was that VAT area, 
WC and WHtR performed similarly, lending support to 
the current recommendation of using the WC measure-
ment for the diagnosis of MetS.
VAT accumulation is an important predictor of MetS 
[32] and is more closely associated with MetS risk than 
SAT due to its greater lipolytic activity and higher 
Table 1 Participant characteristics
Values are mean (standard deviation) or median (interquartile range)
BMI (WHO classification) body mass index, WC waist circumference, WHR waist- 
to- hip ratio, WHtR waist- to -height-ratio, ABSI A Body Shape Index, VAT visceral 
adipose tissue
Variable Overall
n 204
Age (years) 53.1 (13.7)
Body composition
 Height (m) 1.56 (0.06)
 Weight (kg) 79.3 (18.3)
 BMI (kg/m2) 32.6 (7.2)
 WC (cm) 99 (15.0)
 Hip (cm) 113 (14.0)
 WHR 0.88 (0.07)
 WHtR 0.64 (0.1)
 ABSI 0.078 [0.075–0.082]
 Body fat (%) 44.0 (39.8–48.6)
 Body fat (kg) 31.2 (24.4–40.0)
VAT area  (cm2) 181.2 [134.7–235.0]
Cardiometabolic risk factors
 Fasting glucose (mmol/L) 6.3 (3.3)
 Fasting serum insulin (µU/mL) 8.4 (5.7–12.7)
 Triglycerides (mmol/L) 1.6 (1.0)
 LDL-cholesterol (mmol/L) 3.3 (1.0)
 HDL-cholesterol (mmol/L) 1.3 (0.3)
 Total cholesterol (mmol/L) 5.4 (1.2)
 Systolic blood pressure (mmHg) 127 (21)
 Diastolic blood pressure (mmHg) 82 (12)
Metabolic syndrome (JIS)
 High waist circumference (n(%)) 181 (88.7)
 High blood pressure (n(%)) 151 (74.0)
 High fasting blood glucose (n(%)) 68 (33.5)
 High triglycerides (n(%)) 70 (34.3)
 Low HDL (n(%)) 98 (48.0)
 3 components or more (n(%)) 116 (57.1)
Table 2 Comparison of  the  performance of  anthropometric variables and  VAT area in  the  discrimination of  any two 
components of metabolic syndrome (not including the WC criteria in the analysis)
ABSI A Body Shape Index, AUC area under the receiver-operating characteristic curve, BMI body mass index, Hip hip circumference, WC waist circumference, WHR 
waist-to-hip ratio, WHtR waist-to-height ratio, 95% CI 95% confidence interval
Variables AUC (95% CI) p value for differences in AUC 
vs BMI vs WC vs Hip vs WHR vs WHtR vs ABSI vs VAT area
BMI 0.716 (0.643–0.788) – 0.187 0.002 0.703 0.109 0.014 0.028
WC 0.738 (0.667–0.810) 0.187 – 0.0005 0.288 0.413 0.0004 0.192
Hip 0.664 (0.587–0.741) 0.002 0.0005 – 0.528 0.001 0.132 0.0004
WHR 0.698 (0.624–0.771) 0.703 0.288 0.528 – 0.181 < 0.0001 0.083
WHtR 0.747 (0.675–0.819) 0.109 0.413 0.001 0.181 – 0.0001 0.397
ABSI 0.575 (0.495–0.655) 0.014 0.0004 0.132 < 0.0001 0.0001 – < 0.0001
VAT area 0.767 (0.700–0.834) 0.028 0.192 0.0004 0.083 0.397 < 0.0001 –
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inflammatory profile [15]. WC is an internationally rec-
ognized surrogate for VAT and one of the five JIS criteria 
for the diagnosis of MetS [4]. As WC and other anthro-
pometric measurements are however unable to discrimi-
nate between VAT and SAT, we set out to determine 
whether VAT would perform better than these measures 
and could therefore be used in risk prediction. Notably, 
we found that DXA- derived VAT did not perform bet-
ter that WC and some of the other measures of central 
adiposity in diagnosing MetS in this sample. A possible 
explanation for this is that abdominal SAT is heterog-
enous, is of greater volume than VAT and has similar 
metabolic activity to VAT, thus also impacting on the 
development of insulin resistance and MetS [12]. The 
larger volume of SAT vs. VAT is particularly true for 
women compared to men, with abdominal SAT meas-
ured at L4–L5 being roughly five fold greater than VAT 
in the same location [12]. Moreover, abdominal SAT can 
be divided at the level of the fascia superficialis into deep 
(dSAT) and superficial SAT (sSAT), with the dSAT hav-
ing higher metabolic activity and inflammatory profile 
than sSAT, and intermediate to VAT [33]. This suggests 
that the metabolic effects of accumulation of both VAT 
and abdominal SAT on MetS risk may be additive. Other 
studies have shown that VAT area performs better than 
WC, WHtR and WHR in determining MetS risk. For 
example, the results of the cross-sectional Netherlands 
epidemiology of Obesity study involving mostly white 
middle-aged obese women indicated that MRI-derived 
VAT was most strongly associated with cardiometabolic 
risk factors followed by WC and WHR [34]. Likewise in 
a study in Japanese women, CT-derived VAT performed 
better than WC in predicting MetS [35]. In contrast, and 
similar to our findings, Evans et al. [36] found that WC, 
WHtR and a CT-derived measure of VAT performed 
similarly in predicting MetS in pre-menopausal black 
and white South African women. These findings may be 
explained by ethnic-specific associations between adi-
pose tissue distribution and insulin sensitivity. Indeed, 
studies have shown that VAT was the most significant 
correlate of insulin sensitivity in white women, whereas 
in black women, SAT performed similarly or better to 
VAT [37]. Another possible explanation for VAT not 
performing significantly better than WC and WHtR in 
diagnosing MetS may lie in the methodological limitation 
of imaging to precisely distinguish the various anatomi-
cal adipose tissue compartments [38]. Although DXA-
derived VAT and SAT have been validated against the 
gold standard imaging methods such as CT and MRI in 
other ethnic groups [17, 18], they have not yet been vali-
dated in a mixed ancestry population. Additionally, DXA 
is unable to differentiate between dSAT and sSAT.
When comparing the performance of the VAT area 
and WC thresholds for detecting any two components of 
MetS in this sample, we found that the sensitivity of VAT 
area was higher than WC (73% vs 61%), but the specific-
ity was lower (70% vs 80.8%). The implication of this is 
that VAT may be more sensitive than WC to detect MetS, 
but may also over diagnose MetS in screening. Further-
more, the accuracy and PPV of the WC and VAT area, 
as well as the DOR were very similar, reiterating the view 
that there may not be any advantage of using the more 
costly measurement of VAT in the clinical setting.
Fig. 1 Receive operating characteristic curves (ROC) using visceral adipose tissue area (VAT) and waist circumference (WC) for the prediction of the 
presence of at least two components of the metabolic syndrome. Se sensitivity, Sp specificity (using the Youden Index)
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In contrast to WC and WHtR, we found that VAT area 
performed better than BMI, HC, WHR and ABSI in diag-
nosing any two components of MetS. A possible reason 
for this is that the latter anthropometry measures are 
essentially measures of total adiposity, which is not as 
closely associated with MetS as central adiposity [7]. For 
example, several studies have shown weak correlations 
for ABSI in predicting MetS [39, 40]. Similarly in a large 
cross-sectional study in an Iranian population, BMI had 
the lowest AUC in women for predicting Mets [41]. WC 
only requires one measurement unlike BMI and ABSI 
which requires height to be measured which can be chal-
lenging in the clinical setting [42].
The optimal VAT area for predicting any 2 components 
of MetS (other than WC) in this sample was 174 cm2 (CI 
137.7–181.5). This is higher than the ≥ 163 cm2 found in 
peri and post-menopausal African and Caucasian Ameri-
can women [19]. Our VAT thresholds were also consid-
erably higher than those used to predict metabolic risk 
variables in black (> 48 cm2) and white (> 107 cm2) pre-
menopausal SA women [36]. Notably, recommended 
VAT cut points for diagnosing any two components of 
MetS (other than WC) differ by age and ethnicity [19, 35, 
36]. Indeed, studies have shown that for the same BMI or 
WC, black women have less VAT than white women [43]. 
Further, it is well known that VAT accumulation occurs 
at menopause [44], and that VAT and total fat mass are 
independent with regards to metabolic risk [45], support-
ing the notion that WC corresponding to critical levels 
of VAT area may be age specific [19, 35]. This is sup-
ported by results of the study by Evans et al. [36] which 
identified considerably lower CT-derived VAT thresholds 
(> 88  cm2) for MetS risk factors in younger pre-meno-
pausal white South African women than those recom-
mended for peri- and post-menopausal women from our 
study (174 cm2) and others (≥ 163 cm2) [19].
The strengths of the study are that we derived WC and 
VAT area cut-points specific to this sample, which ena-
bled us to directly compare the performance of these 
cut-points to diagnose any 2 components of MetS. Addi-
tionally, the two statistical approaches used to derive the 
cut-points yielded very similar results, an indication that 
the relationships are consistent. Furthermore, this is the 
first study to measure DXA-derived VAT area in mixed 
ancestry South African women. Although CT and MRI 
are considered the gold-standard for measuring VAT 
area, DXA has been proven to be an accurate imaging 
tool for deriving VAT [18]. The limitations of this study 
are that the sample included mostly post-menopausal 
women and thus the results cannot be generalised to 
younger women or men given that there are specific age 
and sex thresholds for WC that correspond to critical 
levels of VAT  cm2 [19, 35]. Additionally, the sample size 
was relatively small, yielding unstable estimates. A larger 
representative study is needed to determine whether 
VAT performs better than WC for diagnosing MetS and 
if shown to be better, ethnic, sex and age specific cut-
points developed.
Conclusion
Our study showed that there is no advantage of measur-
ing VAT over WC in the diagnosis of MetS as VAT area, 
WC and WHtR performed similarly in predicting two 
components of MetS in this sample of mixed ancestry 
South African women. WC is easier to measure in the 
clinical setting than other anthropometric measures and 
an universally recognised proxy for central adiposity.
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